DOI: 10.2337/diaspect.21.2.69 © 2008 by the American Diabetes Association
Transparency: Where Have All the Experts Gone?
I have been involved in the care of people with diabetes for more than 25 years. My role began as a trial coordinator for the Diabetes Control and Complications Trial (DCCT) in 1982, as well as studies that brought human insulin to market. Over the years, I have also had the privilege of building a clinical practice of children and adults. The scope of my clinical research has included major National Institutes of Health clinical trials, pharmaceutical studies, and device research. From a clinical perspective, the richness of this mix allows me to be on the cutting edge of the best diabetes care at all times. I have also been afforded the opportunity to be a consultant and advisor to many of the diabetes pharmaceutical and device companies. This provides me an additional edge in terms of the latest diabetes care, which I can also transfer to my clinical practice. It also means that, in this era of "transparency," I must be ever diligent and proactive in disclosing my dualities of interest.
Over time, the American Diabetes Association (ADA) has stressed the
importance of all volunteers, including health care professionals, serving as
fundraisers for the cause of diabetes. With my many contacts in the
pharmaceutical industry, I have been able to assist in securing major gifts
from these companies
|
| |||||||||||||||||||||||||||